APA (7th ed.) Citation

Sciurba, F., Criner, G. J., Christenson, S. A., Martinez, F. J., Papi, A., Roche, N., . . . Pavord, I. D. (2025). Mepolizumab to prevent exacerbations of COPD with an eosinophilic phenotype. The New England journal of medicine, 392(17), . https://doi.org/10.1056/NEJMoa2413181

Chicago Style (17th ed.) Citation

Sciurba, Frank, et al. "Mepolizumab to Prevent Exacerbations of COPD with an Eosinophilic Phenotype." The New England Journal of Medicine 392, no. 17 (2025). https://doi.org/10.1056/NEJMoa2413181.

MLA (9th ed.) Citation

Sciurba, Frank, et al. "Mepolizumab to Prevent Exacerbations of COPD with an Eosinophilic Phenotype." The New England Journal of Medicine, vol. 392, no. 17, 2025, https://doi.org/10.1056/NEJMoa2413181.